top of page
Backgrounds.jpg

The voice of Colville and northeastern Washington since 1896

|

September 15, 2026

Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

iShares Biotechnology ETF (NQ:IBB)

209.31 -1.22 (-0.58%)
Delayed Quote Updated: 10:53 AM EDT, Oct 1, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about iShares Biotechnology ETF

< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
28 29 Next >
News headline image
Disinflation Talk Grows, Rate Hike Bets Plummet: Top 5 ETFs Rallying On CPI Miss ↗
The disinflationary trend continued in July, even though the annual CPI inflation rate saw a slight increase from 3% to 3.2% last month, breaking a streak of 12 consecutive months of decline. 
Via Benzinga
Topics ETFs Economy
News headline image
5 Magnificent ETFs to Buy Hand Over Fist for the Second Half of 2023 ↗
These exchange-traded funds (ETFs) offer low or ultralow net expense ratios and are perfectly positioned to help investors grow their wealth. 
Via The Motley Fool
News headline image
The July 6-Month Calendar Range SPY QQQ IWM TLT ↗
Looking at the SPY chart, we have had 7 trading days above the range high. However, to date, SPY has not really taken off from that level and sits more in consolidation mode. 
Via Talk Markets
News headline image
Now That The July 6-Month Calendar Range Is Set ↗
As this week begins with a test of the July 6-month calendar range high, should that level break down, it could mean a substantially wide trading range in store for the small caps. 
Via Talk Markets
News headline image
3 Top ETFs to Buy Right Now ↗
These three exchange-traded funds could be winning plays for patient investors. 
Via The Motley Fool
News headline image
Rising Stars, Falling Trends: July's Industry ETF Winners And Losers ↗
 
Via Benzinga
News headline image
On A Winning Streak! Many Market Signs Appear More Bullish ↗
This past week corporate earnings announcements picked up speed. You may recall that we mentioned the large money center Banks had announced the week before. If you did not read last week’s issue, you... 
Via Talk Markets
News headline image
Major Sector ETFs Re-Set In July-Blueprint ↗
Retail XRT is in a Distribution phase and has to clear the 200-WMA and calendar range high at 67.42. A move under 63.40 would be weak. 
Via Talk Markets
News headline image
Playbook Revisited As UNH Beat Could Help Sagging Healthcare Stocks ↗
Last week saw a broadening of the rally as many top sectors were up over 3%. But healthcare was among the laggards up only 0.7%. 
Via Talk Markets
News headline image
Biotech Blues: Stay Balanced Through July Earnings Season ↗
Life Science stocks lack momentum so be prepared for rebalancing and rotation shifts. 
Via Talk Markets
News headline image
Moderna: Declining Performance And Relative Weakness
Moderna's value has declined by over 75% from its peak as the world moves on from the COVID-19 pandemic, leading to concerns about its investment appeal. 
Via MarketBeat
Topics ETFs
News headline image
Biotech And Healthcare Stocks Lagging ↗
Healthcare is a laggard with XLV down YTD but UNH is still a core position. 
Via Talk Markets
News headline image
Is the Biotech Industry (IBB) Poised For A Major Breakout?
The current consolidation in the IBB signals a potential breakout might be looming as key moving averages have converged within a contracted price range. 
Via MarketBeat
Topics ETFs
News headline image
Rotation Out Of Healthcare And Biotech Stocks: Age Of Disruption? ↗
A steady rotation out of biotech and healthcare stocks into the Nasdaq-100 large-cap tech stocks can be unnerving for portfolio managers. 
Via Talk Markets
News headline image
3 Biotech Stocks to Avoid Like the Plague ↗
Investors are looking for bargains in the biotech sector. But these three biotech stocks should be avoided at all costs. 
Via InvestorPlace
News headline image
Sunnier Skies This Past Week, But Will It Last? ↗
The stock market rallied out of a long sideway consolidation pattern and made a new year-to-date high as well as a positive 52-week period. The S&P 500 was up 1.71%, and the Nasdaq 100 was up 3.53% for... 
Via Talk Markets
News headline image
Technical And Fundamental Analysis On US Oil Fund ↗
Energy, gas, and oil are the underperformers this year and the main reason many call for deflation, recession, or at the very least, the end of accelerating inflation. 
Via Talk Markets
News headline image
Time To Play Small Cap Life Science Stocks ↗
The overall market sentiment has been hit hard by MACRO concerns. The dominating narrative is the Fed and the Debt Ceiling. 
Via Talk Markets
News headline image
Biotech ETFs Pop On M&A Resurgence ↗
The biopharma industry has seen a recent upswing in mergers and acquisitions (M&A). 
Via Talk Markets
News headline image
Small & Mid Cap Life Science Stock Portfolio: Some Good Picks In A Stalled Sector ↗
A pivotal week looks to be shaping up with the usual macro concerns arising, such as a Fed meeting and big earnings waiting just around the corner. One possible path to help navigate around these macro... 
Via Talk Markets
News headline image
Healthcare Sector Update: MedTech Trending Up ↗
Earnings from major device companies and large-cap biopharma over the next two weeks will help us ascertain risks for the market. 
Via Talk Markets
News headline image
The Economic Modern Family & the MOST IMPORTANT Data Ever ↗
Bitcoin (BTC), defies all the talking heads. While Sister Semiconductors is our Wonder Woman, Bitcoin is our Rebel with a Cause. BTC closed the week at new yearly highs! 
Via Talk Markets
News headline image
Mifepristone Abortion Pill Access in Limbo: Justice Department May Ask Supreme Court's Intervention ↗
U.S. Attorney General Merrick Garland said that the Justice Department would file an appeal with the U.S. Supreme Court seeking to block the entirety of Kacsmaryk's order suspending the FDA approval of... 
Via Benzinga
News headline image
Women's Reproductive Rights: US Court Preserves Access To Abortion Pill For Now, But With Tighter Rules ↗
A U.S. federal appeals court has temporarily blocked a decision by a Texas judge to halt the FDA's approval of a widely used abortion drug. 
Via Benzinga
News headline image
Trillions In Biotech Stock Gains Trace Back To This Financier ↗
Frank did not grow up as son of a Wall Street banker. He began as the consummate outsider. 
Via Investor's Business Daily
News headline image
New York and California Prepare For Potential Mifepristone Ban In Texas With Stockpiling Of Alternative Abortion Medications ↗
New York and California are stockpiling an alternative abortion medication in case a Texas judge's order suspending the FDA approval of the primary drug, mifepristone, goes into effect later this... 
Via Benzinga
News headline image
Attorney Generals of Over 20 States Sound Alarm Over Suspension Of Abortion Med Approval: "Devastating Risks" Ahead ↗
In a new court filing, the Democratic attorneys general for 23 U.S. states have reportedly warned that a federal judge's decision to suspend the FDA's approval of mifepristone "presents devastating... 
Via Benzinga
News headline image
April Is Busting Out For Healthcare And Biotech ↗
Last week was a good week for healthcare stocks and most large cap biopharmaceutical stocks resumed an upward trend. 
Via Talk Markets
News headline image
FDA Withdraws Lone Premature Birth Drug Makena Over Lack of Proven Benefits ↗
 
Via Benzinga
News headline image
AbbVie, Thermo Fisher Scientific And A Must-Watch Biotech ETF: CNBC's 'Final Trades' ↗
On CNBC’s "Halftime Report Final Trades," Bryn Talkington of Requisite Capital Management said she is sticking with AbbVie Inc. (NYSE: ABBV), which has a 7.3% free cash flow yiel 
Via Benzinga
< Previous 1 2
...
5 6 7 8 9 10 11 12 13
...
28 29 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.
bottom of page